First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial-Reference-Cited by-同舟云学术

First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial

Published:2021-10 Issue: Volume:156 Page:35-45
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Guo Ye,Luo Yi,Zhang Qingyuan,Huang Xiaoming,Li Zhengdong,Shen Liangfang,Feng Jifeng,Sun Yan^ORCID,Yang Kunyu,Ge Minghua,Zhu Xiaodong,Wang Lin,Liu Yanyan,He Xiaohui,Bai Chunmei,Xue Kai,Zeng Yan,Chang XinYing,Chen Wenfeng,Lin Tongyu

Funder

Merck KGaA

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines;D’cruz;Oral Oncol,2013

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

3. Global patterns and trends in cancers of the lip, tongue and mouth;Miranda-Filho;Oral Oncol,2020

4. World Health Organization: International Agency for Research on Cancer. Cancer Today. Accessed August 6, 2021. [https://gco.iarc.fr/]

5. National Comprehensive Cancer Network. Head and Neck Cancers (Version 1.2020). Accessed August 6, 2021. [https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendations/GetFileFromFileManager?fileManagerId=7573]

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial;Nature Medicine;2024-06-28

2. Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?;Expert Review of Anticancer Therapy;2024-05-13

3. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway;HISTOL HISTOPATHOL;2024

4. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer;International Journal of Molecular Sciences;2024-04-03

5. Global burden of head and neck cancers from 1990 to 2019;iScience;2024-03